iSpecimen operates a digital marketplace that connects researchers with a global network of biospecimen providers, facilitating access to millions of human biospecimens, including tissues and biofluids. This platform addresses the critical shortage of high-quality specimens that limits research capabilities in the life sciences sector.
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Life science researchers often face challenges in acquiring the necessary human biospecimens, such as tissues and biofluids, due to limited access and difficulties in navigating a fragmented landscape of specimen providers. This scarcity of high-quality, well-annotated samples can significantly impede research progress and delay the development of new diagnostics and therapeutics.
Solution
iSpecimen operates a digital marketplace connecting researchers with a global network of biospecimen providers, streamlining the procurement process and offering access to a diverse range of human biospecimens. The platform enables researchers to efficiently search for and acquire specimens that meet their specific project requirements, including diagnostic remnant, banked, and prospectively collected samples. By aggregating a wide variety of sample types, disease states, and accompanying clinical data, iSpecimen simplifies biospecimen matchmaking and reduces the time spent on sourcing critical research materials. The marketplace facilitates compliant and efficient transfer of biospecimens, contributing to biomedical advances by connecting researchers with the specimens they need.
Target Audience
The primary target audience includes medical researchers in the life sciences industry who require human biospecimens for research and development, as well as biorepositories seeking to expand their reach and streamline biospecimen sharing.
Features
- Online marketplace connecting researchers with a global network of biospecimen providers.
- Access to millions of human biospecimens, including biofluids, tissue samples, and stem and immune cells.
- Options for diagnostic remnant, banked, or prospective collections.
- Availability of matched sample sets of human biospecimens, including matched tissue, blood, and other biofluids.
- Access to pre-screened cancer tumor tissue samples characterized by next-generation DNA and RNA sequencing.
- Streamlined specimen procurement process, reducing R&D timelines.